Pemafibrate
Pemafibrate[edit | edit source]
Pemafibrate is a novel fibrate drug that acts as a selective peroxisome proliferator-activated receptor (PPAR) alpha modulator. It is primarily used for the treatment of dyslipidemia, particularly in reducing triglyceride levels and improving lipid profiles in patients with hyperlipidemia.
Mechanism of Action[edit | edit source]
Pemafibrate functions by selectively modulating the activity of the PPAR-alpha receptor, which plays a crucial role in the regulation of lipid metabolism. By activating PPAR-alpha, pemafibrate enhances the oxidation of fatty acids and increases the catabolism of triglyceride-rich particles, leading to a reduction in plasma triglyceride levels. This mechanism also contributes to an increase in high-density lipoprotein (HDL) cholesterol levels.
Clinical Use[edit | edit source]
Pemafibrate is indicated for the treatment of hyperlipidemia, particularly in patients who have not achieved adequate control of their lipid levels through diet and lifestyle modifications alone. It is often prescribed to patients with hypertriglyceridemia to reduce the risk of cardiovascular disease.
Pharmacokinetics[edit | edit source]
Pemafibrate is administered orally and is well absorbed in the gastrointestinal tract. It undergoes hepatic metabolism and is primarily excreted in the urine. The drug has a favorable pharmacokinetic profile, with a long half-life that allows for once-daily dosing.
Side Effects[edit | edit source]
Common side effects of pemafibrate include mild gastrointestinal disturbances, such as nausea and diarrhea. Some patients may experience muscle pain or myopathy, although these effects are less common compared to other fibrates. Regular monitoring of liver function tests is recommended during treatment.
Comparison with Other Fibrates[edit | edit source]
Compared to traditional fibrates like fenofibrate and gemfibrozil, pemafibrate offers a more selective action on PPAR-alpha, which may result in a better safety profile and fewer drug interactions. Its selectivity also contributes to its efficacy in lowering triglyceride levels and improving HDL cholesterol.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
